ATP,Creatine Phosphate and Glycogen Content in Human Myocardial Biopsies: Markers for the Efficacy of Cardioprotection During Aorto-Coronary Bypass Surgery
Restricted accessResearch articleFirst published online May, 1984
ATP,Creatine Phosphate and Glycogen Content in Human Myocardial Biopsies: Markers for the Efficacy of Cardioprotection During Aorto-Coronary Bypass Surgery
Measurements of the myocardial content of ATP, creatine phosphate and glycogen provide a sensitive marker of the effect of inevitably global ischemia on myocardial tissue during aorto-coronary bypass surgery and give insight in the efficacy of various cardioprotective techniques. Continuous aortic cross clamping for performance of the distal anastomoses with multidose St. Thomas cardioplegia did not result in significant changes in the myocardial ATP, creatine phosphate and glycogen content. In contrast, hypothermic intermittent crossclamping resulted in a significant reduced tissue content of these markers of myocardial ischemia.
Get full access to this article
View all access options for this article.
References
1.
Hearse DJ, Braimbridge MV and Jynge P.: Protection of the Ischemic Myocardium: Cardioplegia. New York, Raven Press, 1980, p. 3.
2.
Laughlin L., Bailey L., Willis W., et al: Myocardial preservation. A comparison of local hypothermia with and without cold cardioplegia. J Thorac Cardiovasc Surg80:289, 1980.
3.
Salerno TA and Choing MA: Cardioplegic arrest in pigs. J Thorac Cardiovasc Surg80:929, 1980.
4.
Engelman RM, Rousou JH, O'Donoghue MJ, et al: A comparison of intermittent and continuous arrest for prolonged hypothermic cardioplegia. Ann Thorac Surg29:217, 1980.
5.
Hearse DJ, Stewart DA and Braimbridge MV: The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the rat. J Thorac Cardiovasc Surg79:39, 1980.
6.
Barner HB, Laks H., Codd JE, et al: Cold blood as the vehicle for potassium cardioplegia. Ann Thorac Surg28:509, 1979.
7.
Jynge P., Hearse DJ and Braimbridge MV: Myocardial protection during ischemic cardiac arrest. J Thorac Cardiovasc Surg73:848, 1977.
8.
Flameng W., Borgers M., Daenen W. and Stalpaert G.: Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man. J Thorac Cardiovasc Surg79:413, 1980.
9.
Lamprecht W. and Trautschold I.: Determination of Adenosine Triphosphate: Methods of Enzymatic Analysis. New York, Academic Press, 1974, p. 2101.
10.
Lamprecht W., Stein P., Heinz F. and Weisser H.: Determination of Creatine Phosphate: Methods of Enzymatic Analysis. New York, Academic Press, 1974, p. 1777.
11.
Drake AJ, Papadoyannis DE, Butcher RG, et al: Inhibition of glycolysis in the denervated dog heart. Circ Res47:338, 1980.
12.
Grover FL, Gewel JG, Ghidon JJ, et al: Effects of ventricular fibrillation on coronary blood flow and myocardial metabolism. J Thorac Cardiovasc Surg73:616, 1977.
13.
Reimer KA, Jennings RB and Hill ML: Total ischemia in dog hearts in vitro. 2. High-energy phosphate depletion and associated defects in energy metabolism, cell volume regulation, and sarcolemmal integrity. Circ Res49:901, 1981.
